Oral procainamide was administered to a 68-year-old male with short bowel syndrome resulting from small bowel infarction. Therapeutic procainamide levels were achieved in this patient with a markedly reduced absorptive surface. The limited data regarding absorption of other drugs in short bowel syndrome are also reviewed.
Get full access to this article
View all access options for this article.
References
1.
Weser E.: Nutritional aspects of malabsorption: Short gut adaptation. Am J Med67:1014-1020, 1979
2.
Urban E.: Metabolic consequence of small bowel resection. Short bowel syndrome . Gastroenterology77:572-579, 1979
3.
Mitchell JFMaas LCBarger RC, et al: Successful oral anticoagulant therapy in a patient with short bowel syndrome. Am J Hosp Pharm34:171-172, 1977
4.
Krausz MM, Berry E., Freund U., et al: Absorption of orally administered digoxin after massive resection of the small bowel. Am J Gastroenterol71:220-223, 1979
5.
Kennedy MC, Wade DN: Phenytoin absorption in patients with ileojejunal bypass. Br J Clin Pharmacol7:515-518, 1979
6.
Marcus FI, Quinn EJ, Horton H.: The effect of jejunoileal bypass on the pharmacokinetics of digoxin in man . Circulation55:537-540, 1977
7.
Johansson ED , Krai JG: Oral contraceptives after intestinal bypass operation. JAMA236:2847, 1976
8.
Backman L., Beerman B., Groschinsky-Grind M., et al: Malabsorption of hydrochlorothiazide following intestinal shunt surgery. Clin Pharmacokinet4:63-68, 1979
9.
Koch-Weser J. : Pharmacokinetics of procainamide in man. Ann NY Acad Sci179:370-382, 1971
10.
Weliky I., Neiss ES: Absorption of procainamide from the human intestine. Clin Pharmacol Ther17:248, 1975
